// App-Quantinova.ai

THU0015 : TYPE I INTERFERON SIGNATURE PREDICTS PROGRESSION TO INFLAMMATORY ARTHRITIS IN ACPA+ AT-RISK INDIVIDUALS WITHOUT CLINICAL SYNOVITIS

Researchers

Presenter

  • L. Garcia-Montoya

Principal Investigators

  • Z. Wigston

  • A. Burska

  • K. Mankia

  • E. Vital

  • P. Emery

Medical Centers

  • University of Leeds, Leeds, United Kingdom

  • Leeds Biomedical Research Centre, NIHR, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

Biomarkers

  • C reactive protein

  • Peripheral blood mononuclear cell

Drug/Treatment

  • Interferon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • AstraZeneca.

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved